BSE filing, NSE: TRF. Summary written from the filing by ALFA Finder's alert engine.
TRF Ltd: key numbers
- Share price
- ₹200.54
- Market cap
- ₹220.7 Cr
- Revenue (annual)
- ₹85.03 Cr
- Net profit (annual)
- ₹-4.47 Cr
- P/E (TTM)
- 4.4×Sector 52.0×
- Promoter holding
- 34.12%+0.00% QoQ
- FII holding
- 0.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TRF Ltd
All →TRF Capital Structure Change
Counter Cyclical Investments Private Limited acquired 12,670 shares of TRF Ltd via open market transactions, increasing their stake to 5.37%.
TRF Q2 FY27 Results: Turns Profitable, Net Profit ₹49.8 Cr
TRF Ltd reported revenue from operations of ₹36 Cr (+61.4% YoY) and net profit of ₹49.8 Cr for Q2 FY27.
- Key figure
- Net profit ₹49.8 Cr
TRF Board Meeting Date
TRF Ltd notified exchanges of a board meeting on 13 Oct 2026 to consider Q1 and H1 FY27 financial results. Trading window closes 24 Sep 2026 until results declaration.
TRF Capital Structure Change
Counter Cyclical Investments bought 13,767 TRF Ltd shares in open market, raising its stake from 5.02% to 5.15%. No transaction value was disclosed in this SAST Reg 29(2) filing.
TRF Management Change
TRF Limited announced the resignation of Mr. Abhijeet Singh and the appointment of Ms. Shubhra Singh as the new Chief Human Resources Officer, effective September 15, 2026.
TRF Capital Structure Change
Counter Cyclical Investments Private Limited acquired 3,982 shares of TRF Ltd, increasing its stake to 5.02% via open market purchase.
- Promoter stake change
- +0.03%
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.